← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #560 OF 1,000 MOST-CITED

Proof Of Identity

FDA cited this observation 33 times across 31 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Biologics33
BY FISCAL YEAR
FY20262
FY20252
FY20242
FY20225
FY20212
FY201912
FY20184
FY20174

How FDA worded it — real examples

Failure to obtain from the donor on the day of donation a postal address where the donor may be contacted for 8 weeks after donation.

Children's Hospital of Orange County · Orange, California · Biologics · 2026-04-29

Failure to obtain from the donor on the day of donation a postal address where the donor may be contacted for 8 weeks after donation.

Guam Memorial Hosp Authority · Tamuning, Guam · Biologics · 2026-03-06

Failure to obtain from the donor on the day of donation a postal address where the donor may be contacted for 8 weeks after donation.

Hoxworth Blood Center University of Cincinnati · Cincinnati, Ohio · Biologics · 2025-09-08

Failure to obtain from the donor on the day of donation proof of identity.

Hendrick Regional Blood Center · Abilene, Texas · Biologics · 2025-06-27

Failure to obtain from the donor on the day of donation a postal address where the donor may be contacted for 8 weeks after donation.

Carter BloodCare - Texoma · Sherman, Texas · Biologics · 2024-08-23

Failure to obtain from the donor on the day of donation a postal address where the donor may be contacted for 8 weeks after donation.

University of California Irvine Medical Center Campus Donor Center · Irvine, California · Biologics · 2024-05-15

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →